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Rapid developments in geographical information systems (GIS)
continue to generate interest in analyzing complex spatial datasets.
One area of activity is in creating smoothed disease maps to de-
scribe the geographic variation of disease and generate hypotheses
for apparent differences in risk. With multiple diseases, a multivariate
conditionally autoregressive (MCAR) model is often used to smooth
across space while accounting for associations between the diseases.
The MCAR, however, imposes complex covariance structures that are
difficult to interpret and estimate. This article develops a much sim-
pler alternative approach building upon the techniques of smoothed
ANOVA (SANOVA). Instead of simply shrinking effects without any
structure, here we use SANOVA to smooth spatial random effects
by taking advantage of the spatial structure. We extend SANOVA
to cases in which one factor is a spatial lattice, which is smoothed
using a CAR model, and a second factor is, for example, type of
cancer. Datasets routinely lack enough information to identify the
additional structure of MCAR. SANOVA offers a simpler and more
intelligible structure than the MCAR while performing as well. We
demonstrate our approach with simulation studies designed to com-
pare SANOVA with different design matrices versus MCAR with dif-
ferent priors. Subsequently a cancer-surveillance dataset, describing
incidence of 3-cancers in Minnesota’s 87 counties, is analyzed using
both approaches, showing the competitiveness of the SANOVA ap-
proach.
1. Introduction. Statistical modeling and analysis of spatially referenced
data receive considerable interest due to the increasing availability of geo-
graphical information systems (GIS) and spatial databases. For data aggre-
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gated over geographic regions such as counties, census tracts or ZIP codes
(often called areal data), with individual identifiers and precise locations
removed, inferential objectives focus on models for spatial clustering and
variation. Such models are often used in epidemiology and public health to
understand geographical patterns in disease incidence and morbidity. Recent
reviews of methods for such data include Lawson et al. (1999), Elliott et al.
(2000), Waller and Gotway (2004) and Rue and Held (2005). Traditionally
such data have been modeled using conditionally specified probability mod-
els that shrink or smooth spatial effects by borrowing strength from neigh-
boring regions. Perhaps the most pervasive model is the conditionally au-
toregressive (CAR) family pioneered by Besag (1974), which has been widely
investigated and applied to spatial epidemiological data [Wakefield (2007)
gives an excellent review]. Recently the CAR has been extended to multivari-
ate responses, building on multivariate conditional autoregressive (MCAR)
models described by Mardia (1988). Gelfand and Vonatsou (2003) and Carlin
and Banerjee (2003) discussed their use in hierarchical models, while Kim,
Sun and Tsutakawa (2001) presented a different “twofold CAR” model for
counts of two diseases in each areal unit. Other extensions allowing flexible
modeling of cross-correlations include Sain and Cressie (2002), Jin, Car-
lin and Banerjee (2005) and Jin, Banerjee and Carlin (2007). The MCAR
can be viewed as a conditionally specified probability model for interactions
between space and an attribute of interest. For instance, in disease map-
ping interest often lies in modeling geographical patterns in disease rates or
counts of several diseases. The MCAR acknowledges dependence between
the diseases as well as dependence across space. However, practical difficul-
ties arise from MCAR’s elaborate dependence structure: most interaction
effects will be weakly identified by the data, so the dependence structure is
poorly identified. In hierarchical models [e.g., Gelfand and Vonatsou (2003),
Jin, Carlin and Banerjee (2005, 2007)], strong prior distributions may im-
prove identifiability, but this is not uncontroversial, as inferences are sensi-
tive to the prior and perhaps unreliable without genuine prior information.
This article proposes a much simpler and more interpretable alternative to
the MCAR, modeling multivariate spatial effects using smoothed analysis of
variance (SANOVA) as developed by Hodges, Carlin and Fan (2007), hence-
forth HCSC. Unlike an ANOVA that is used to identify some interaction
effects to retain and others to remove, SANOVA mostly retains effects that
are large, mostly removes those that are small, and partially retains middling
effects. (Loosely speaking, “large,” “middling” and “small” describe the size
of the unsmoothed effects compared to their standard errors.) To accommo-
date rich dependence structures, MCAR introduces weakly identifiable pa-
rameters that complicate estimation. SANOVA, on the other hand, focuses
instead on smoothing interactions to yield more stable and reliable results.
Our intended contribution is to show how SANOVA can solve the multiple
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disease mapping problem while avoiding the dauntingly complex covariance
structures imposed by MCAR and its generalizations. We demonstrate that
SANOVA produces inference that is largely indistinguishable from MCAR,
yet SANOVA is simpler, more explicit, easier to put priors on and easier to
estimate. The rest of the article is as follows. Section 2 reviews SANOVA
and MCAR, identifying SANOVA as a special case of MCAR. Section 3 is a
“tournament” of simulation experiments comparing SANOVA with MCAR
for normal and Poisson data, while Section 4 analyzes data describing the
number of deaths from lung, larynx and esophagus cancer in Minnesota
between 1990 and 2000. A summary and discussion of future research in
Section 5 concludes the paper. Zhang, Hodges and Banerjee (2009) (Appen-
dices) gives computational and technical details.
2. The competitors.
2.1. Smoothing spatial effects using SANOVA.
2.1.1. SANOVA for balanced, single-error-term models [HCSC (2007)].
Consider a balanced, single-error-term analysis of variance, with M1 de-
grees of freedom for main effects andM2 degrees of freedom for interactions.
Specify this ANOVA as a linear model: let A1 denote columns in the de-
sign matrix for main effects, and A2 denote columns in the design matrix
for interactions. Assume the design has c cells and n observations per cell,
giving cn observations in total. To simplify later calculations, normalize the
columns of A1 and A2 so A
′
1A1 = IM1 and A
′
2A2 = IM2 . (Note: HCSC nor-
malized columns differently, fixing A′1A1 = cnIM1 and A
′
2A2 = cnIM2 .) Then
write the ANOVA as
y= [A1|A2]
[
Θ1
Θ2
]
+ ǫ=A1Θ1 +A2Θ2 + ǫ,(1)
where ǫ ∼ N(0, 1η0 I) with η0 being a precision, y is cn × 1, A1 is cn ×
M1, A2 is cn ×M2, Θ1 is M1 × 1, Θ2 is M2 × 1, and ǫ is cn × 1. This
ANOVA is smoothed by further modeling Θ. HCSC emphasized smooth-
ing interactions, although main effects can be smoothed by exactly the
same means. Following HCSC, we add constraints (or a prior) on Θ2 as
θM1+j ∼N(0,1/ηj) for j = 1, . . . ,M2, written as
0M2 = [0M2×M1 |IM2 ]
[
Θ1
Θ2
]
+ δ,(2)
where δ ∼ N(0,diag( 1ηj )), in the manner of Lee and Nelder (1996) and
Hodges (1998). Combining (1) and (2), express this hierarchical model as a
linear model: [
y
0M2
]
=
[
A1 A2
0M2×M1 IM2
][
Θ1
Θ2
]
+
[
ǫ
δ
]
.(3)
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More compactly, write
Y=XΘ+ e,(4)
where Y has dimension (cn+M2)×1 and e’s covariance Γ is block diagonal
with blocks Γ1 =
1
η0
Icn for the data cases (rows of X corresponding to the
observation y) and Γ2 = diag(1/η1, . . . ,1/ηM2) for the constraint cases (rows
of X with error term δ). For convenience, define the matrix XD = [A1|A2],
the data-case part of X . This development can be done using the mixed
linear model (MLM) formulation traditionally written as y=Xβ+Zu+ ǫ,
where our (1) supplies this equation and u=Θ2 ∼N(0,Γ2). The develop-
ment to follow can also be done using the MLM formulation at the price
of slightly greater complexity, so we omit it. HCSC developed SANOVA for
exchangeable priors on groups formed from components of Θ2. The next
section develops the extension to spatial smoothing.
2.1.2. What is CAR? Suppose a map has N regions, each with an un-
known quantity of interest φi, i = 1, . . . ,N . A conditionally autoregressive
(CAR) model specifies the full conditional distribution of each φi as
φi | φj, j 6= i,∼N
(
α
mi
∑
i∼j
φj ,
1
τmi
)
, i, j = 1, . . . ,N,(5)
where i∼ j denotes that region j is a neighbor of region i (typically defined
as spatially adjacent), andmi is the number of region i’s neighbors. Equation
(5) reduces to the well-known intrinsic conditionally autoregressive (ICAR)
model [Besag, York and Mollie´ (1991)] if α= 1 or an independence model if
α = 0. The ICAR model induces “local” smoothing by borrowing strength
from neighbors, while the independence model assumes spatial independence
and induces “global” smoothing. The CAR prior’s smoothing parameter α
also controls the strength of spatial dependence among regions, though it
has long been appreciated that a fairly large α may be required to induce
large spatial correlation; see Wall (2004) for recent discussion and examples.
It is well known [e.g., Besag (1974)] that the conditional specifications in
(5) lead to a valid joint distribution for φ= (φ1, . . . , φN )
′ expressed in terms
of the map’s neighborhood structure. If Q is an N × N matrix such that
Qii =mi, Qij =−α whenever i∼ j and Qij = 0 otherwise, then the intrinsic
CAR model [Besag, York and Mollie´ (1991)] has density
p(φ|τ)∼ τN∗/2 exp
(
−τ
2
φ′Qφ
)
, with
(6)
N∗ =
{
N, if α ∈ (0,1),
N −G, if α= 1.
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In (6) τ is the spatial precision parameter, τQ is the precision matrix in
this multivariate normal distribution and G is the number of “islands” (dis-
connected parts) in the spatial map [Hodges, Carlin and Fan (2003)]. When
α ∈ (0,1), (6) is a proper multivariate normal distribution. When α= 1, Q is
singular with Q1= 0; Q has rank N −G in a map with G islands, therefore,
the exponent on τ becomes (N − G)/2. In hierarchical models, the CAR
model is usually used as a prior on spatial random effects. For instance, let
Yi be the observed number of cases of a disease in region i, i = 1, . . . ,N ,
and Ei be the expected number of cases in region i. Here the Yi are treated
as random variables, while the Ei are treated as fixed and known, often
simply proportional to the number of persons at risk in region i. For rare
diseases, a Poisson approximation to a binomial sampling distribution for
disease counts is often used, so a commonly used likelihood for mapping a
single disease is
Yi
ind∼ Poisson(Eieµi), i= 1, . . . ,N,(7)
where µi = x
′
iβ+ φi. The xi are explanatory, region-specific regressors with
coefficients β and the parameter µi is the log-relative risk describing depar-
tures of observed from expected counts, that is, from Ei. The hierarchy’s
next level is specified by assigning the CAR distribution to φ and a hyper-
prior to the spatial precision parameter τ . In the hierarchical setup, the
improper ICAR with α = 1 gives proper posterior distributions for spatial
effects. In practice, Markov chain Monte Carlo (MCMC) algorithms are de-
signed for estimating posteriors from such models and the appropriate num-
ber of linear constraints on the φ suffices to ensure sampling from proper
posterior distributions [Banerjee, Carlin and Gelfand (2004), pages 163–164,
give details].
2.1.3. How does CAR fit into SANOVA? To use CAR in SANOVA, the
key is re-expressing the improper CAR, that is, (6) with α= 1. Let Q have
spectral decomposition Q= V DV ′, where V is an orthogonal matrix with
columns containing Q’s eigenvectors and D is diagonal with nonnegative
diagonal entries. D has G zero diagonal entries, one of which corresponds
to the eigenvector 1√
N
1N , by convention the N th (right-most) column in
V . Define a new parameter Θ= V ′φ, so Θ has dimension N and precision
matrix τD. Giving an N -vector Θ a normal prior with mean zero and preci-
sion τD is equivalent to giving φ= VΘ a CAR prior with precision τQ. Θ
consists of ΘN =
1√
N
1′Nφ=
√
N φ, the scaled average of the φi, along with
N −1 contrasts in φ, which are orthogonal to 1√
N
1N by construction. Thus,
the CAR prior is informative (has positive precision) only for contrasts in
φ, while putting zero precision on ΘGM =ΘN =
1√
N
1′Nφ, the overall level,
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and on G− 1 orthogonal contrasts in the levels of the G islands. In other
words, the CAR model can be thought of as a prior distribution on the
contrasts rather than individual effects (hence the need for the sum-to-zero
constraint). A related result, discussed in Besag, York and Mollie´ (1995),
shows the CAR to be a member of a family of “pairwise difference” pri-
ors. This reparameterization allows the CAR model to fit into the ANOVA
framework, with ΘGM corresponding to the ANOVA’s grand mean and the
rest ofΘ,ΘReg , corresponding to V
(−)′φ, where V (−) is V excluding the col-
umn 1√
N
1N , consisting of N − 1 orthogonal contrasts among the N regions
and giving the N − 1 degrees of freedom in the usual ANOVA:
φ= [φ1, φ2, . . . , φN ]
′
= VΘ
=
[
V (−) 1√
N
1N
][ΘReg
ΘGM
]
.
Giving φ a CAR prior is equivalent to giving Θ a N(0, τD) prior; the latter
are the “constraint cases” in HCSC’s SANOVA structure. The precision
DNN = 0 for the overall level is equivalent to a flat prior on ΘGM , though
ΘGM could alternatively have a normal prior with mean zero and finite
variance. If G> 1, the CAR prior also puts zero precision on G−1 contrasts
in φ, which are contrasts in the levels of the G islands [Hodges, Carlin and
Fan (2003)].
2.2. SANOVA as a competitor to MCAR.
2.2.1. Multivariate conditionally autoregressive (MCAR) models. With
multiple diseases, we have unknown φij corresponding to region i and dis-
ease j, where i= 1, . . . ,N and j = 1, . . . , n. Letting Ω be a common precision
matrix (i.e., inverse of the covariance matrix) representing correlations be-
tween the diseases in a given region, MCAR distributions arise through
conditional specifications for φi = (φi1, . . . , φin)
′:
φi|{φi′}i′ 6=i ∼MVN
(
α
mi
∑
i′∼i
φi′ ,
1
mi
Ω−1
)
.(8)
These conditional distributions yield a joint distribution for φ= (φ′1, . . . ,φ
′
N )
′:
f(φ|Ω)∝ ‖Ω‖(N−G)/2 exp (−12φ′(Q⊗Ω)φ),(9)
where Q is defined as in Section 2.1.2 and again (9) is an improper den-
sity when α = 1. However, as for the univariate CAR, this yields proper
posteriors in conjunction with a proper likelihood. The specification above
is a “separable” dispersion structure, that is, the covariances between the
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diseases are invariant across regions. This may seem restrictive, but relax-
ing this restriction gives even more complex dispersion structures [see Jin,
Banerjee and Carlin (2007) and references therein]. As mentioned earlier, our
focus is to retain the model’s simplicity without compromising the primary
inferential goals. We propose to do this using SANOVA and will compare it
with the separable MCAR only.
2.2.2. SANOVA with Minnesota counties as one factor. We now de-
scribe the SANOVA model using the Minnesota 3-cancer dataset. Con-
sider the Minnesota map with N = 87 counties, and suppose each county
has counts for n = 3 cancers. County i has an n-vector of parameters de-
scribing the n cancers, φi = (φi1, φi2, . . . , φin)
′; define the Nn vector φ as
φ= (φ′1,φ
′
2, . . . ,φ
′
N )
′. For now, we are vague about the specific interpreta-
tion of φij ; the following description applies to any kind of data. Assume
the N × N matrix Q describes neighbor pairs among counties as before.
The SANOVA model for this problem is a 2-way ANOVA with factors can-
cer (“CA,” n levels) and county (“CO ,” N levels) and no replication. As
in Section 2.1.1, we model φ with a saturated linear model and put the
grand mean and the main effects in their traditional positions as in ANOVA
(matrix dimensions and definitions appear below the equation):
φ= [φ′1,φ
′
2, . . . ,φ
′
N ]
′ = [A1|A2]Θ
=
[ ∣∣∣∣(10) 1√Nn1Nn︸ ︷︷ ︸
Grand mean
Nn×1
1√
N
1N ⊗HCA︸ ︷︷ ︸
Cancer
main effect
Nn×(n−1)
V (−) ⊗ 1√
n
1n︸ ︷︷ ︸
County
main effect
Nn×(N−1)
V (−) ⊗H(1)CA · · · V (−) ⊗H(n−1)CA︸ ︷︷ ︸
Cancer×County
interaction
Nn×(N−1)(n−1)
]
×

ΘGM
ΘCA
ΘCO
ΘCO×CA
 ,
where HCA is an n × (n − 1) matrix whose columns are contrasts among
cancers, so 1′nHCA = 0
′
n−1, and H
′
CAHCA = In−1; H
(j)
CA is the jth column
of HCA; and V
(−) is V without its N th column 1√
N
1N , so it has N − 1
columns, each a contrast among counties, that is, 1′NV
(−) = 0′N−1, and
V (−)′V (−) = IN−1. The column labeled “Grand mean” corresponds to the
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ANOVA’s grand mean and has parameter ΘGM ; the other blocks of columns
labeled as main effects and interactions correspond to the analogous ANOVA
effects and to their respective parameters ΘCA,ΘCO ,ΘCO×CA. Defining
prior distributions on Θ completes the SANOVA specification. We put in-
dependent flat priors (normal with large variance) on ΘGM and ΘCA, which
are, therefore, not smoothed. This is equivalent to putting a flat prior on
each of the n cancer-specific means. To specify the smoothing priors, de-
fine H
(0)
CA =
1√
n
1n. Let the county main effect parameter ΘCO have prior
ΘCO ∼NN−1(0, τ0D(−)), where D(−) corresponds to V (−), that is, D with-
out its N th row and column, τ0 > 0 is unknown and τ0D
(−) is a precision
matrix. Similarly, let the jth group of columns in the cancer-by-county in-
teraction, V (−) ⊗H(j)CA, have prior Θ(j)CO×CA ∼ NN−1(0, τjD(−)), for τj > 0
unknown. Each of the priors on ΘCO and the Θ
(j)
CO×CA is a CAR prior; the
overall level of each CAR, with prior precision zero, has been included in
the grand mean and cancer main effects.
To compare this to the MCAR model, use SANOVA’s priors on Θ to
produce a marginal prior for φ comparable to the MCAR’s prior on φ (Sec-
tion 2.2.1); in other words, integrate ΘCO and ΘCO×CA out of the foregoing
setup. A priori, K

ΘCO
Θ
(1)
CO×CA
...
Θ
(n−1)
CO×CA

(11)
has precision Q⊗(H(+)A diag(τj)H(+)A ′), whereK is the columns of the design
matrix for the county main effects and cancer-by-county interactions—the
right-most n(N − 1) columns in equation (10)’s design matrix—and H(+)A =
( 1√
n
1n|HCA) is an orthogonal matrix. Appendix A in Zhang, Hodges and
Banerjee (2009) gives a proof.
2.2.3. Comparing SANOVA vs MCAR. Defining φ as in Sections 2.2.1
and 2.2.2, consider the MCAR prior for φ, with within-county precision
matrix Ω. Let Ω have spectral decomposition VΩDΩV
′
Ω, where DΩ is n× n
diagonal and VΩ is n× n orthogonal. Then the prior precision of φ is Q⊗
(VΩDΩV
′
Ω), where Q is the known neighbor relations matrix and VΩ and DΩ
are unknown. Comparing MCAR to SANOVA, the prior precision matrices
for the vector φ are as in Figure 1. SANOVA is clearly a special case of
MCAR in which H
(+)
A is known. Also, as described so far, H
(+)
A has one
column proportional to 1n with the other columns being contrasts, while
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Fig. 1. Comparing prior precision matrices for φ in MCAR and SANOVA.
MCAR avoids this restriction. MCAR is thus more flexible, while SANOVA
is simpler, presumably making it better identified and easier to set priors for.
MCAR should have its biggest advantage over SANOVA when the “true”
VΩ is not like H
(+)
A for any specification of the smoothing precisions τj .
However, because data sets often have modest information about higher-
level variances, it may be that using the wrong H
(+)
A usually has little effect
on the analysis. In other words, SANOVA’s performance may be relatively
stable despite having to specify H
(+)
A , while MCAR may be more sensitive
to Ω’s prior.
2.3. Setting priors in MCAR and SANOVA.
2.3.1. Priors in SANOVA. For the case of normal errors, based on equa-
tions (1) and (10), setting priors for Θ, τj, η0 completes a Bayesian specifica-
tion. Since τ and η0 are precision parameters, one possible prior is Gamma;
this paper uses a Gamma with mean 1 and variance 10. As mentioned, the
grand mean and cancer main effects θ1, θ2, θ3 have flat priors with π(θ)∝ 1,
though they could have proper informative priors. The priors for θ4, . . . are
set according to the SANOVA structure as in Section 2.2.2. We ran chains
drawing in the order θ, τ and η0 [Appendix B in Zhang, Hodges and Banerjee
(2009) gives details]. Hodges, Carlin and Fan (2007) also considered priors on
the degrees of freedom in the fitted model, some conditioned so the degrees
of freedom in the model’s fit were fixed at a certain degree of smoothness.
The present paper emphasizes comparing MCAR and SANOVA, so we do
not consider such priors. For the case of Poisson errors, we use a normal
prior with mean 0 and variance 106 for the grand mean and cancer main
effects θ1, θ2, θ3. The other θis are given normal CAR priors as discussed in
Section 2.2.2. For the prior on the smoothing precisions τj , we use Gamma
with mean 1 and variance 10. To reduce high posterior correlations among
the θs, we used a transformation during MCMC; Appendix C in Zhang,
Hodges and Banerjee (2009) gives details.
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2.3.2. Priors in MCAR. MCAR models were fitted in WinBUGS. For
the normal-error case, we used this model and parameterization:
Yij ∼N
(
µij ,
1
η0
)
,
(12)
µij = βj + Sij ,
i = 1, . . . ,N ; j = 1, . . . , n, where η0 has a gamma prior with mean 1 and
variance 10 as for SANOVA. To satisfy WinBUGS’s constraint that
∑
i Sij =
0, we add cancer-specific intercepts βj . We give βj a flat prior and for S, the
spatial random effects, we use an intrinsic multivariate CAR prior. Similarly,
in the Poisson case
Yij ∼ Poisson(µij),
(13)
log(µij) = log(Eij) + βj + Sij,
where Eij is an offset. Prior settings for βj and Sij are as in the nor-
mal case. For MCAR priors, the within-county precision matrix Ω needs
a prior; a Wishart distribution is an obvious choice. If Ω ∼Wishart(R,ν),
then E(Ω) = νR−1. We want a “vague” Wishart prior; usually ν = n is used
but little is known about how to specify R. Thus, we considered three dif-
ferent Rs, each proportional to the identity matrix. One of these priors sets
R’s diagonal entries to Rii = 0.002, close to the setting used in an example
in the GeoBUGS manual (oral cavity cancer and lung cancer in West York-
shire). The other two Rs are the identity matrix and 200 times the identity.
For the special case n = 1, where the Wishart reduces to a Gamma, these
Wisharts are Γ(0.5,0.001), Γ(0.5,0.5) and Γ(0.5,100), respectively.
3. Simulation experiment. For this simulation experiment, artificial data
were simulated from the model used in SANOVA with a spatial factor, as
described in Section 2.2.2. Three different types of Bayesian analysis were
applied to the simulated data: SANOVA with the same H
(+)
A used to gener-
ate the simulated data (called “SANOVA correct”); SANOVA with incorrect
H
(+)
A ; and MCAR. SANOVA correct is a theoretical best possible analysis
in that it takes as known things that MCAR estimates, that is, it uses ad-
ditional correct information. SANOVA correct cannot be used in practice,
of course, because the true H
(+)
A is not known. MCAR vs SANOVA with
incorrect H
(+)
A is the comparison relevant to practice, and comparing them
to SANOVA correct shows how much each method pays for its “deficiency”
relative to SANOVA correct. Obviously it is not enough to test the SANOVA
model using only data generated from a similar SANOVA model. To avoid
needless computing and facilitate comparisons, instead of generating data
from an MCAR model and fitting a SANOVA model as specified above, we
use a trick that is equivalent to this. Section 3.1.2 gives the details.
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3.1. Design of the simulation experiment. We simulated both normally-
distributed and Poisson-distributed data. For both types of data, we consid-
ered two different true sets of smoothing parameters r= τ/η0 or τ (Table
1). For the normal data, we considered τ/η0, since this ratio determines
smoothing in normal models, and we also considered two error precisions η0
(Table 1).
3.1.1. Generating the simulated data sets. To generate data from the
SANOVA model, we need to define the true H
(+)
A . Let
HA1 =
1 −2 01 1 −1
1 1 1


1√
3
0 0
0 1√
6
0
0 0 1√
2
 .
We used HA1 as the correct H
(+)
A ; its columns are scaled to have length 1.
Given V (−) and with H(+)A known, one draw of Θ and ǫ produces a draw of
XDΘ+ ǫ, therefore a draw of y. In the simulation, we let the grand mean
and main effects, which are not smoothed, have true value 5. Each observa-
tion is simulated from a 3× 20 factorial design, where 3 is the number of
cancers and 20 is the number of counties. We used the 20 counties in the
right lower corner of Minnesota’s map, with their actual neighbor relations.
Thus, the dimension of each artificial data set is 60. The simulation experi-
ment is a repeated-measures design, in which a “subject” s in the design is
a draw of (δ(s),γ(s)), referring to equation (3), where δ
(s)
1−3 = 5 and δ
(s)
4−60 ∼
N57(0, I3 ⊗D(−)) specify Θ and γ(s) ∼N60(0, I60) gives ǫ. For the normal-
errors case, 100 such “subjects” were generated. Given a design cell in the
simulation experiment with τ = (a, b, c) and η0 = d, the artificial data set for
subject s is y(s) =XD diag(1
′
3,
1√
a
1′19,
1√
b
1′19,
1√
c
1′19)δ
(s) + 1√
d
γ(s). All fac-
tors of the simulation experiment were applied to each of the 100 “subjects.”
For the normally-distributed data, the simulation experiment had these fac-
tors: (a) the true (τ0/η0, τ1/η0, τ2/η0): (100,100,0.1) or (0.1,100,0.1); (b) the
Table 1
Experimental conditions in the simulation experiments
Error distribution η
0
(τ0/η0,τ1/η0,τ 2/η0)|(τ0,τ 1,τ2) Data name
Normal 1 (100, 100, 0.1) Data1
1 (0.1, 100, 0.1) Data2
10 (100, 100, 0.1) Data3
10 (0.1, 100, 0.1) Data4
Poisson NA (100, 100, 0.1) Data5
NA (0.1, 100, 0.1) Data6
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true error precision η0: 1 or 10; and (c) six statistical methods, described
below in Section 3.1.2. Each design cell described in Table 1 thus had 100
simulated data sets. Similarly, for the Poisson-data experiment, another 100
“subjects” were generated, but now there is no γ(s). Thus, each “subject”
s is a vector δ(s), where δ(s) is as described above. For the design cell with
τ = (100,100,0.1), the artificial data for subject s is y(s) ∼ Poisson(µ(s)),
where log(µ(s)) = log(E)+XD diag(1
′
3,
1
101
′
19,
1
101
′
19,
1√
0.1
1′19)δ
(s). In the sim-
ulation experiment, we use “internal standardization” of the Minnesota 3-
cancer data to supply the expected numbers of cancers Eij . Among the 20
extracted counties, Hennepin county has the largest average population over
11 years, about 1.1 million; its cancer counts are 5294, 119 and 439 for lung,
larynx and esophagus respectively. Faribault county has the smallest average
population, 16,501, with cancer counts 110, 7 and 13 respectively. The Eij
have ranges 80 to 5275, 2 to 113 and 7 to 449 for lung, larynx and esoph-
agus cancer respectively. For the Poisson data, the simulation experiment
had these factors: (a) the true τ0, τ1, τ2: (100,100,0.1) or (0.1,100,0.1); and
(b) six statistical methods described below in Section 3.1.2. Again, each of
the two design cells in Table 1 had 100 simulated data sets.
3.1.2. The six methods (procedures). For each simulated data set, we
did a Bayesian analysis for each of six different models described in Table 2.
The six models are: SANOVA with the correct H
(+)
A , HA1; SANOVA with a
somewhat incorrect H
(+)
A , HA2 given below; a variant SANOVA with a very
incorrect H
(+)
A , HAM given below; MCAR with Rii = 0.002; MCAR with
Rii = 1; and MCAR with Rii = 200 (see Section 2.3.2). HA2 and HAM are
HA2 =
1 1 11 −2 0
1 1 −1


1√
3
0 0
0 1√
6
0
0 0 1√
2
 ,
Table 2
The six statistical methods used in the simulation experiment
Procedure Prior
SANOVA with correct H
(+)
A η0, τj ∼ Γ(0.1,0.1) for j = 0,1,2
SANOVA with incorrect H
(+)
A η0, τj ∼ Γ(0.1,0.1) for j = 0,1,2
Variant SANOVA with HAM η0, τj ∼ Γ(0.1,0.1) for j = 0,1,2
MCAR Ω∼Wishart(R,3), R= 0.002I3
MCAR Ω∼Wishart(R,3), R= I3
MCAR Ω∼Wishart(R,3), R= 200I3
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HAM =
 0.56 −0.64 −0.52−0.53 −0.77 0.36
−0.63 0.07 −0.77
 .
The incorrect HA2 has the same first column (grand mean) as the correct
HA1, so it differs from the correct HA1, though less than it might. As noted
above, we need to see how the SANOVA model performs for data generated
from an MCAR model in which VΩ from Figure 1 does not have a column
proportional to 1n. To do this without needless computing, we used a trick:
we used the data generated from a SANOVA model with HA1 and fit the
variant SANOVA mentioned above, in which H
(+)
A is replaced by the or-
thogonal matrix HAM with no column proportional to 1n, chosen to be very
different from HA1. For normal errors (Data1 through Data4), this is pre-
cisely equivalent to fitting a SANOVA with H
(+)
A = HA1 to data generated
from an MCAR model with VΩ =BHA1, for B =HA1H
−1
AM , that is,
VΩ =
 0.43 −0.74 −0.52−0.13 −0.63 0.77
−0.89 −0.26 −0.37
(14)
(to 2 decimal places). For Poisson errors (Data5, Data6), the equivalence
is no longer precise but the divergence of fitted SANOVA [using H
(+)
A =
HAM ] and generated data [using H
(+)
A = HA1] is quite similar. Finally, we
considered three priors for MCAR because little is known about how to set
this prior and we did not want to hobble MCAR with an ill-chosen prior.
For the SANOVA and variant SANOVA analyses, we gave τj a Γ(0.1,0.1)
prior with mean 1 and variance 10 for both the normal data and the Poisson
data.
3.2. Outcome measures. To compare the six different methods for nor-
mal and Poisson data, we consider three criteria. The first is average mean
squared error (AMSE). For each of the 60 (XDΘ)ij , the mean squared error
is defined as the average squared error over the 100 simulated data sets.
AMSE for each design cell in the simulation experiment is defined as the
average of mean squared error over the 60 (XDΘ)ij . Thus, for the design
cell labeled DataK in Table 1, define
ÂMSEK =
1
L
L∑
d=1
N∑
i=1
n∑
j=1
[(XDΘ̂)
d
ij − (XDΘ)dij ]2/Nn,(15)
where L = 100,N = 20, n = 3,K = 1, . . . ,4 for Normal, K = 5,6 for Pois-
son, Θ is the true value and Θ̂ is the posterior median of Θ. For each
design cell (K), the Monte Carlo standard error for AMSE is (100)−0.5
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Table 3
AMSE for simulated normal and Poisson data
Normal-error model Poission-error model
Model Data1 Data2 Data3 Data4 Data5 Data6
SANOVA with HA1 0.34 0.60 0.04 0.06 0.02 0.04
SANOVA with HA2 0.47 0.84 0.05 0.07 0.02 0.14
SANOVA with HAAM 0.48 0.74 0.05 0.06 0.03 0.11
MCAR with Rii = 0.002 0.66 1.88 0.04 0.13 0.02 0.04
MCAR with Rii = 1 0.36 0.84 0.04 0.06 0.02 0.06
MCAR with Rii = 200 0.93 0.92 0.09 0.09 0.24 0.36
times the standard deviation, across DataK’s 100 simulated data sets, of∑N
i=1
∑n
j=1[(XDΘ̂)
d
ij − (XDΘ)dij]2/Nn. The second criterion is the bias of
XDΘ. For each of DataK’s 100 simulated data sets, first compute posterior
medians of (XDΘ)1,1, . . . , (XDΘ)20,3, then average each of those posterior
medians across the 100 simulated data sets. From this average, subtract
the true (XDΘ)ijs to give the estimated bias for each of the 60 (XDΘ)ijs.
MBIAS is defined as the 2.5th, 50th and 97.5th percentiles of the 60 esti-
mated biases. More explicitly, for design cell DataK, MBIAS is
M̂BIASK = 2.5th,50th,97.5th percentiles of
(16) (
1
L
L∑
d=1
(XDΘ̂
d −XDΘd)
)
.
Finally, the coverage rate of Bayesian 95% equal-tailed posterior intervals,
“PI rate,” is the average coverage rate for the 60 individual (XDΘ)ijs.
3.3. Markov chain Monte Carlo specifics. While the MCAR models were
implemented in WinBUGS, our SANOVA implementations were coded in R
and run on Unix. The different architectures do not permit a fair compar-
ison between the run times of SANOVA and MCAR. However, the SANOVA
models have lower computational complexity than the MCARmodels: MCAR
demands a spectral decomposition in every iteration, while SANOVA does
not. For each of our models, we ran three parallel MCMC chains for 10,000
iterations. The CODA package in R (www.r-project.org) was used to di-
agnose convergence by monitoring mixing using Gelman–Rubin diagnostics
and autocorrelations [e.g., Gelman et al. (2004), Section 11.6]. Sufficient
mixing was seen within 500 iterations for the SANOVA models, while 200
iterations typically revealed the same for the MCAR models; we retained
8000× 3 samples for the posterior analysis.
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3.4. Results. Table 3 and Figures 2 and 3 show the simulation experi-
ment’s results. Table 3 shows AMSE; for all methods and design cells, the
standard Monte Carlo errors of AMSE are small, less than 0.07, 0.005 and
0.025 for Data1/Data2, Data3/Data4 and Data5/Data6 respectively. Figure
2 shows MBIAS, where the middle symbols represent the median bias and
the line segments represent the 2.5th and 97.5th percentiles. Figure 3 shows
coverage of the 95% posterior intervals. Denote SANOVA with the correct
H
(+)
A (HA1) as “SANOVA correct,” SANOVA with HA2 as “SANOVA in-
correct,” the variant SANOVA with HAM as “SANOVA variant,” MCAR
with Rii = 0.002 as “MCAR0.002” and so on.
3.4.1. As expected, SANOVA with correct H
(+)
A performs best. For nor-
mal data, SANOVA correct has the smallest AMSE for all true η0 and τ
(Table 3). The advantage is larger in Data1 and Data2 where the error pre-
cision η0 is 1 than in Data3 and Data4 where η0 is 10 (i.e., error variation is
smaller). For Poisson data, SANOVA correct also has the smallest AMSE.
Considering MBIAS (Figure 2), SANOVA correct has the narrowest MBIAS
intervals for all cases. In Figure 3, the posterior coverage for SANOVA cor-
rect is nearly nominal. As expected, then, SANOVA correct performs best
among the six methods.
3.4.2. SANOVA with incorrect HA2 and HAM perform very well. Table 3
shows that, for normal data, both SANOVA incorrect and SANOVA variant
have smaller AMSEs than MCAR200 and MCAR0.002, and AMSEs at worst
close to MCAR1’s. For Poisson data, Table 3 shows that MCAR0.002 and
MCAR1 do somewhat better than SANOVA incorrect and variant SANOVA.
Fig. 2. MBIAS for simulated normal and Poisson data.
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Fig. 3. PI rate for simulated normal and Poisson data.
Considering MBIAS in normal data [Figure 2(a)], the width of the 95%
MBIAS intervals for SANOVA incorrect are the same as or smaller than
for all three MCAR procedures. Similarly, SANOVA variant has MBIAS
intervals better than MCAR0.002 and MCAR200 and almost as good as
MCAR1. Figure 2(b) for Poisson data shows SANOVA correct, MCAR0.002
and MCAR1 have similar MBIAS intervals. SANOVA variant in Data5 and
SANOVA incorrect in Data6 show the worst performance for MBIAS apart
from MCAR200, whose MBIAS interval is much the widest. Figure 3(a)
shows that, for normal data, interval coverage for SANOVA incorrect and
SANOVA variant is very close to nominal. It appears that the specific value
of H
(+)
A has little effect on PI coverage rate for the cases considered here.
Apart from MCAR200 for Data1/Data2 and MCAR0.002 for Data1 through
Data4, which show low coverage, all the other methods have coverage rates
greater than 90% for normal data, most close to 95%. For Data3 and Data4,
PI rates for MCAR200 reach above 99%. For Poisson data, the PI rates for
SANOVA incorrect and SANOVA variant are close to nominal and better
than MCAR0.002 and MCAR200. In particular, all SANOVAs have the
closest to nominal coverage rates for both normal and Poisson data, which
again shows the stability of SANOVA under different H
(+)
A settings.
3.4.3. MCAR is sensitive to the prior on Ω. To fairly compare SANOVA
and MCAR, we considered MCAR under three different prior settings. For
normal data, MCAR1 has the smallest AMSEs and narrowest MBIAS in-
tervals among the MCARs considered, while MCAR0.002 has the largest
and widest, respectively. For Poisson data, however, MCAR0.002 has the
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best AMSE and MBIAS among the MCARs. MCAR200 performs poorly
for both Normal and Poisson. The coverage rates in Figure 3 show similar
comparisons. These results imply that the prior matters for MCAR: no sin-
gle prior was always best. By comparison, SANOVA seems more robust, at
least for the cases considered.
3.5. Summary. As expected, SANOVA correct had the best performance
because it uses more correct information. For normal data, SANOVA incor-
rect and SANOVA variant had similar AMSEs, better than two of the three
MCARs for the data sets considered. For Poisson data, SANOVA incorrect
and SANOVA variant had AMSEs as good as those of MCAR0.002 and
MCAR1 for Data5 and somewhat worse for Data6, while showing nearly
nominal coverage rates in all cases and less tendency to bias than MCAR
in most cases. Replacing the Γ(0.1,0.1) prior for τ with Γ(0.001,0.001) left
AMSE and MBIAS almost unchanged and coverage rates a bit worse (data
not shown). MCAR, on the other hand, seems more sensitive to the prior
on Ω. MCAR0.002 tends to smooth more than MCAR1, more so in normal
models where the prior is more influential than in Poisson models. (The lat-
ter is true because data give more information about means than variances,
and the Poisson model’s error variance is the same as its mean, while the nor-
mal model’s is not.) For the normal data, MCAR0.002’s tendency to extra
shrinkage appears to make it oversmooth and perform poorly for Data2 and
Data4, where the truth is least smooth. For the Poisson data, MCAR0.002
and MCAR1 give results similar to each other and somewhat better than
the SANOVAs except for interval coverage. Therefore, SANOVA, with stable
results under different H
(+)
A and with parameters that are easier to under-
stand and interpret, may be a good competitor to MCAR in multivariate
spatial smoothing.
4. Example: Minnesota 3-cancer data. Researchers in different fields have
illustrated that accounting for spatial correlation could provide insights that
would have been overlooked otherwise, while failure to account for spatial
association could potentially lead to spurious and sometimes misleading re-
sults [see, e.g., Turechek and Madden (2002), Ramsay, Burnett and Krewski
(2003), Lichstein et al. (2002)]. Among the widely investigated diseases are
the different types of cancers. We applied SANOVA and MCAR to a cancer-
surveillance data set describing total incidence counts of 3 cancers (lung,
larynx, esophagus) in Minnesota’s 87 counties for the years 1990 to 2000
inclusive. Minnesota’s geography and history make it plausible that disease
incidence would show spatial association. Three major North American land
forms meet in Minnesota: the Canadian Shield to the north, the Great Plains
to the west, and the eastern mixed forest to the southeast. Each of these re-
gions is distinctive in both its terrain and its predominant economic activity:
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mining and outdoors tourism in the mountainous north, highly mechanized
crop cultivation in the west, and dairy farming in the southeast. The differ-
ent regions were also settled by somewhat different groups of in-migrants,
for example, disproportionately many Scandinavians in the north. These
factors imply spatial association in occupational hazards as well as culture,
weather, and access to health care especially in the thinly-populated north,
which might be expected to produce spatial association in diseases. With
multiple cancers one obvious option is to fit a separate univariate model for
each cancer. But diseases may share the same spatially distributed risk fac-
tors, or the presence of one disease might encourage or inhibit the presence
of another in a region, for example, larynx and esophagus cancer have been
shown to be closely related spatially [Baron et al. (1993)]. Thus, we may
need to account for dependence among the different cancers while main-
taining spatial dependence between sites. Although the data set has counts
broken out by age groups, for the present purpose we ignore age standard-
ization and just consider total counts for each cancer. Age standardization
would affect only the expected cancer counts Eij , while other covariates
could be added to either SANOVA or MCAR as unsmoothed fixed effects
(i.e., in the A1 design matrix). Given the population and disease count of
each county, we estimated the expected disease count for each cancer in each
county using the Poisson model. Denote the 87× 3 counts as y1,1, . . . , y87,3;
then the model is
yij|µij ∼ Poisson(µij),
(17)
log(µij) = log(Eij) + (XDΘ)ij ,
where XDΘ is the SANOVA structure and Θ has priors as in Section 2.2.2.
For disease j in county i, Eij = Pi
∑
iOij∑
i Pi
, where Oij is the disease count for
county i and disease j and Pi is county i’s population. For the SANOVA de-
sign matrix, we consider HA1 and HA2 from the simulation experiment,
though now neither is known to be correct. We also consider a variant
SANOVA analysis using H
(+)
A estimated from the MCAR1 model, to test
the stability of the SANOVA results. Appendix D in Zhang, Hodges and
Banerjee (2009) describes the latter analysis. Figures 4 to 6 show the data
and results for MCAR1 and SANOVA with HA1. In each figure, the upper
left plot shows the observed yij/Eij ; the two lower plots show the posterior
median of µij/Eij for MCAR1 and SANOVA with HA1. Lung cancer counts
tended to be high and thus were not smoothed much by any method, while
counts of the other cancers were much lower and thus smoothed consider-
ably more (see also Figure 7). Since SANOVA with HA1, HA2 and estimated
H
(+)
A gave very similar results, only those for HA1 are shown. Results for
MCAR0.002 are similar to those for MCAR1, so they are omitted. As ex-
pected, MCAR200 shows the least shrinkage among the three MCARs and
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gives some odd µij/Eij . To compare models, we calculated the Deviance In-
formation Criterion [DIC; Spiegelhalter et al. (2002)]. To define DIC, define
the deviance D(θ) = −2 log f(y|θ) + 2 logh(y), where θ is the parameter
vector in the likelihood and h(y) is a function of the data. Since h does not
affect model comparison, we set logh(y) to 0. Let θ be the posterior mean of
θ and D the posterior expectation of D(θ). Then define pD =D(θ)−D(θ)
to be a measure of model complexity and define DIC = D + pD. Table 4
shows D,pD and DIC for nine analyses, SANOVA with 3 different H
(+)
A ,
MCAR with 3 different priors for Ω, and 3 fits of univariate CAR mod-
els to the individual diseases, discussed below. Considering D, the three
SANOVAs and MCAR1 are similar; Figures 4 to 6 show the fits are indeed
similar. Figure 7 reinforces this point, showing that MCAR1 and SANOVA
with HA1 induce similar smoothing for the three cancers. SANOVA with
H
(+)
A estimated from MCAR has the smallest D (1458), though its model
complexity penalty (pD = 103) is higher than MCAR0.002’s (pD = 79). De-
spite having the second worst fit (D), MCAR0.002 has the best DIC, and
the three SANOVAs have DICs much closer to MCAR0.002’s than to the
other MCARs. Generally, all SANOVA models have similar D (≈ 1460) and
DIC (≈ 1562), while MCAR results are sensitive to Ω’s prior, consistent
with the simulation experiment. For comparison, we fit separate univariate
CAR models to the three diseases considering three different priors for the
smoothing precision, τ ∼Gamma(a, a) for a= 0.001, 1 and 1000. For each
prior, we added up D, pD and DIC for three diseases (see Table 4). With
a = 0.001 and 1, we obtained D’s (1461 and 1453 respectively) competi-
tive with SANOVA, MCAR0.002 and MCAR1 but with considerably greater
complexity penalties (141 and 149 respectively) and thus DICs slightly larger
than 1600. For a = 1000, we obtained an even lower D (1432), but an in-
creased penalty (180) resulted in a poorer DIC score. Figure 7 shows fitted
values for CAR1, which were smoothed like MCAR1 and SANOVA for lung
and esophagus cancers but smoothed rather more for larynx cancer. Over-
all, these results reflect some gain in performance from accounting for the
space-cancer interactions/associations.
To further examine the smoothing under SANOVA, Figure 8 shows sep-
arate maps for the county main effect and interactions from the SANOVA
fit with HA1. The upper left plot is the cancer main effect, the mean of
the three cancers; the lower left plot is the comparison of lung versus av-
erage of larynx and esophagus; the lower right plot is the comparison of
larynx versus esophagus. All values are on the same scale as yij/Eij in Fig-
ures 4 to 6 and use the same legend. The two interaction contrasts are
smoothed much more than the county main effect, agreeing with previ-
ous research that larynx and esophagus cancer are closely related spatially
[Baron et al. (1993)]. To see whether the interactions are necessary, we
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Fig. 4. Lung cancer data and fitted values.
fit a SANOVA model (using HA1) without the interactions. As expected,
model complexity decreased (pD = 77), while D increased slightly, so DIC
became 1558, a bit better than SANOVA with interactions. Now consider
the posterior of the MCAR’s precision matrix Ω. The posterior mean of
Ω is much larger for MCAR0.002 than MCAR200; the diagonal elements
are larger by 4 to 5 orders of magnitude. This may explain the poor cov-
erage for MCAR0.002 in the simulation. Further, consider the correlation
matrix arising from the inverse of Ω’s posterior mean. As the diagonals
of R change from 0.002 to 200, the correlation between any two cancers
decreases and the complexity penalty pD increases. By comparison, the
three SANOVAs have similar model fits and complexity penalties, lead-
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Fig. 5. Larynx cancer data and fitted values.
ing to similar DICs. So again, in this sense SANOVA shows greater sta-
bility.
5. Discussion and future work. We used SANOVA to do spatial smooth-
ing and compared it with the much more complex MCAR model. For the
cases considered here, we found SANOVA with spatial smoothing to be an
excellent competitor to MCAR. It yielded essentially indistinguishable in-
ference, while being easier to fit and interpret. In the SANOVA model, H
(+)
A
is assumed known. For most of the SANOVA models considered, H
(+)
A ’s
first column was fixed to represent the average over diseases, while other
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Fig. 6. Esophagus cancer data and fitted values.
columns were orthogonal to the first column. Alternatively, H
(+)
A could be
treated as unknown and estimated as part of the analysis. With this ex-
tension, SANOVA with spatial effects is a reparameterization of the MCAR
model and gains the MCAR model’s flexibility at the price of increased
complexity. This extension would be nontrivial, involving sampling from the
space of orthogonal matrices while avoiding identification problems arising
from, for example, permuting columns of H
(+)
A . Other covariates can be
added to a spatial SANOVA. Although (10) is a saturated model, spatial
smoothing “leaves room” for other covariates. Such models would suffer from
collinearity of the CAR random effects and the fixed effects, as discussed by
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Fig. 7. Comparing data and fitted values for each cancer. The “Data” panel shows the
density for yij/Eij , while the other three panels show the posterior median of µij/Eij for
univariate CAR, SANOVA and MCAR.
Reich, Hodges and Zadnik (2006), who gave a variant analysis that avoids
the collinearity. For data sets with spatial and temporal aspects, for exam-
ple, the 11 years in the Minnesota 3-cancer data, interest may lie in the
counts’ spatial pattern and in their changes over time. By adding a time
effect, SANOVA can be extended to a spatiotemporal model. Besides spa-
tial and temporal main effects, their interactions can also be included and
smoothed. There are many modeling choices; the simplest model is an ad-
ditive model without space-time interactions, where the spatial effect has a
CAR model and the time effect a random walk, which is a simple CAR. But
many other choices are possible. We have examined intrinsic CAR models,
where Qij =−1 if region i and region j are connected. SANOVA with spatial
smoothing could be extended to more general CAR models. Banerjee, Carlin
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Table 4
Model comparison using DIC
Model D pD DIC
SANOVA with HA1 1461 103 1564
SANOVA with HA2 1463 102 1565
SANOVA with HA estimated from MCAR1 1458 103 1561
MCAR0.002 1476 79 1555
MCAR1 1459 132 1591
MCAR200 1559 356 1915
CAR0.001 1461 141 1602
CAR1 1453 149 1602
CAR1000 1432 180 1612
and Gelfand (2004) replaced Q with the matrix Dw−ρW , where Dw is diag-
onal with the same diagonal as Q and Wij = 1 if region i is connected with
region j, otherwise Wij = 0. Setting ρ = 1 gives the intrinsic CAR model
considered in this paper. For known ρ, the SANOVA model described here
is easily extended by replacing Q in Section 2 with Dw − ρW . However, for
unknown ρ, our method cannot be adjusted so easily, because updating ρ in
the MCMC would force V and the design matrix to be updated as well, but
this would change the definition of the parameter Θ. Therefore, a different
approach is needed for unknown ρ. A different extension of SANOVA would
be to survival models for areal spatial data [e.g., Li and Ryan (2002), Baner-
jee, Wall and Carlin (2003), Diva, Dey and Banerjee (2008)]. If the regions
are considered strata, then random effects corresponding to nearby regions
might be similar. In other words, we can embed the SANOVA structure in a
spatial frailty model. For example, the Cox model with SANOVA structure
for subject j in stratum i is
h(tij ,Xij) = h0(tij) exp(Xijβ),(18)
where X is the design matrix, which may include a spatial effect, a tem-
poral effect, their interactions and other covariates. Banerjee, Carlin and
Gelfand (2004) noted that in the CAR model, considering both spatial and
nonspatial frailties, the frailties are identified only because of the prior, so
the choice of priors for precisions is very important. Besides the above ex-
tensions, HCSC introduced tools for normal SANOVA models that can be
extended to nonnormal SANOVA models. For example, HCSC defined the
degrees of freedom in a fitted model as a function of the smoothing preci-
sions. This can be used as a measure of the fit’s complexity, or a prior can
be placed on the degrees of freedom as a way of inducing a prior on the
unknowns in the variance structure. The latter is under development and
will be presented soon.
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Fig. 8. SANOVA with HA1: ( a) county main effect; (b) cancer × county interaction 1
for larynx; ( c) cancer × county interaction 2 for esophagus.
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SUPPLEMENTARY MATERIAL
Appendices, data and code (DOI: 10.1214/09-AOAS267SUPP; .zip). Our
supplementary material includes four sections as appendices. In Appendix
A we present a derivation of the precision matrix of (11). Details of our
MCMC algorithms can be found in Appendix B. Appendix C discusses the
mean transformation for the Poisson case, while Appendix D discusses the
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estimation of the H
(+)
A from MCAR1. In addition, we provide a compressed
folder containing the data set for our 3-cancer Minnesota example as well
as an R code example to implement the SANOVA models.
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